CytoDyn Inc (CYDY)

Name: CytoDyn Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$0.0

Net Income

-$22.6M

Operating Margin

N/A

Free Cash Flow

-$8.8M

Debt / Assets

632.2%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for CytoDyn Inc (CYDY).
Income Statement (Quarterly)	2025-11-30	2025-08-31	2025-02-28	2024-11-30
Revenue	0	0	0	0
Cost of Revenue	5,000	4,000	0	0
Gross Profit	-5,000	-4,000	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,799,000	1,713,000	1,511,000	2,294,000
Operating Expenses	5,096,000	4,565,000	4,003,000	3,707,000
Operating Income	-5,101,000	-4,569,000	-4,003,000	-3,707,000
Interest Expense	651,000	689,000	1,255,000	1,274,000
Income Before Tax	-22,607,000	-5,540,000	-4,758,000	-4,768,000
Income Tax Expense	0	0	0	0
Net Income	-22,607,000	-5,540,000	-4,758,000	-4,768,000
Per Share
EPS	-0.02	0.00	0.00	0.00
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for CytoDyn Inc (CYDY).
Income Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Revenue	-5,916,000	0	0	266,000	0
Cost of Revenue	18,000	29,000	175,000	53,000	0
Gross Profit	-18,000	-29,000	-175,000	213,000	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	7,260,000	10,789,000	17,136,000	44,303,000	34,320,000
Operating Expenses	-11,342,000	18,058,000	40,401,000	72,127,000	94,547,000
Operating Income	11,324,000	-18,058,000	-40,576,000	-71,914,000	-104,596,000
Interest Expense	4,856,000	8,674,000	25,186,000	52,447,000	19,491,000
Income Before Tax	3,745,000	-49,841,000	-79,824,000	-210,820,000	-154,674,000
Income Tax Expense	0	0	12,994,000	77,343,000	0
Net Income	3,745,000	-49,841,000	-79,824,000	-288,163,000	-154,674,000
Per Share
EPS	0.00	-0.05	-0.10	-0.43	-0.27
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for CytoDyn Inc (CYDY).
Balance Sheet (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Assets
Cash and Cash Equivalents	11,903,000	3,110,000	2,541,000	4,231,000
Short Term Investments	0	0	0	0
Net Receivables	2,000,000	0	0	17,929,000
Inventory	0	0	0	17,929,000
Total Current Assets	17,878,000	10,815,000	10,805,000	28,444,000
Property Plant Equipment	0	264,000	400,000	609,000
Goodwill and Intangibles	0	0	0	132,000
Total Assets	18,047,000	11,136,000	11,292,000	29,185,000
Liabilities
Account Payables	14,692,000	29,561,000	62,725,000	67,974,000
Short Term Debt	27,341,000	29,935,000	34,417,000	36,375,000
Total Current Liabilities	70,518,000	84,182,000	119,796,000	123,161,000
Long Term Debt	0	141,000	997,000	422,000
Total Liabilities	114,089,000	127,894,000	120,793,000	123,583,000
Shareholders Equity
Retained Earnings	-887,786,000	-891,531,000	-841,690,000	-766,131,000
Total Shareholders Equity	-96,042,000	-116,758,000	-109,501,000	-94,398,000

Balance sheet annual history for CytoDyn Inc (CYDY).
Balance Sheet (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Assets
Cash and Cash Equivalents	11,903,000	3,110,000	2,541,000	4,231,000	33,943,000
Short Term Investments	0	0	0	0	0
Net Receivables	2,000,000	0	0	17,929,000	0
Inventory	0	0	0	17,929,000	93,479,000
Total Current Assets	17,878,000	10,815,000	10,805,000	28,444,000	129,581,000
Property Plant Equipment	0	264,000	400,000	609,000	846,000
Goodwill and Intangibles	0	0	0	132,000	1,653,000
Total Assets	18,047,000	11,136,000	11,292,000	29,185,000	132,080,000
Liabilities
Account Payables	14,692,000	29,561,000	62,725,000	67,974,000	65,897,000
Short Term Debt	27,341,000	29,935,000	34,417,000	36,375,000	62,922,000
Total Current Liabilities	70,518,000	84,182,000	119,796,000	123,161,000	152,546,000
Long Term Debt	0	141,000	997,000	422,000	552,000
Total Liabilities	114,089,000	127,894,000	120,793,000	123,583,000	153,098,000
Shareholders Equity
Retained Earnings	-887,786,000	-891,531,000	-841,690,000	-766,131,000	-511,294,000
Total Shareholders Equity	-96,042,000	-116,758,000	-109,501,000	-94,398,000	-21,018,000

Cash flow quarterly history for CytoDyn Inc (CYDY).
Cash Flow Statement (Quarterly)	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Operating Activities
Net Income	3,745,000	-49,841,000	-79,824,000	-210,820,000
Depreciation & Amortization	18,000	29,000	175,000	781,000
Stock Based Compensation	1,612,000	2,415,000	4,275,000	6,239,000
Change in Working Capital	-16,172,000	11,658,000	-1,195,000	-4,778,000
Operating Cash Flow	-8,765,000	-10,982,000	-25,110,000	-77,723,000
Investing Activities
Capital Expenditure	0	0	0	0
Investments	0	0	0	0
Investing Cash Flow	0	0	0	0
Financing Activities
Debt Repayment	-710,000	2,011,000	-895,000	0
Common Stock Issued/Repurchased	11,564,000	9,137,000	29,032,000	41,195,000
Dividends Paid	0	0	0	0
Financing Cash Flow	10,854,000	11,748,000	29,927,000	48,011,000
Summary
Free Cash Flow	-8,765,000	-10,982,000	-25,110,000	-77,723,000
Net Change in Cash	2,089,000	766,000	4,817,000	-29,712,000

Cash flow annual history for CytoDyn Inc (CYDY).
Cash Flow Statement (Annual)	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31
Operating Activities
Net Income	3,745,000	-49,841,000	-79,824,000	-210,820,000	-154,674,000
Depreciation & Amortization	18,000	29,000	175,000	781,000	1,797,000
Stock Based Compensation	1,612,000	2,415,000	4,275,000	6,239,000	10,429,000
Change in Working Capital	-16,172,000	11,658,000	-1,195,000	-4,778,000	-20,092,000
Operating Cash Flow	-8,765,000	-10,982,000	-25,110,000	-77,723,000	-117,573,000
Investing Activities
Capital Expenditure	0	0	0	0	-122,000
Investments	0	0	0	0	-122,000
Investing Cash Flow	0	0	0	0	-122,000
Financing Activities
Debt Repayment	-710,000	2,011,000	-895,000	0	-950,000
Common Stock Issued/Repurchased	11,564,000	9,137,000	29,032,000	41,195,000	1,000,000
Dividends Paid	0	0	0	0	-243,000
Financing Cash Flow	10,854,000	11,748,000	29,927,000	48,011,000	137,346,000
Summary
Free Cash Flow	-8,765,000	-10,982,000	-25,110,000	-77,723,000	-117,695,000
Net Change in Cash	2,089,000	766,000	4,817,000	-29,712,000	19,651,000